| Qiu, Wei |
| Completed | 3 | 533 | RoW | Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage | Chipscreen Biosciences, Ltd. | Type 2 Diabetes | 02/23 | 02/23 | | |
NCT06413654: A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) |
|
|
| Recruiting | 2/3 | 132 | RoW | B001, Placebo | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Neuromyelitis Optica Spectrum Disorders | 10/27 | 02/29 | | |
NCT06044350: A Clinical Trial of BAT4406F Injection in Patients with Neuromyelitis Optica Spectrum Disorders |
|
|
| Recruiting | 2 | 162 | RoW | BAT4406F Injection, BAT4406F Placebos | Bio-Thera Solutions | Optic Neuromyelitis Spectrum Disease | 05/25 | 05/26 | | |
NCT04625153: RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial |
|
|
| Recruiting | 2 | 30 | RoW | RC18 160mg, telitacicept, RC18 240mg | RemeGen Co., Ltd. | Multiple Sclerosis, Relapsing-Remitting | 10/25 | 12/25 | | |
NCT04524039: iTBS Study for Depression in Patients With Multiple Sclerosis |
|
|
| Not yet recruiting | N/A | 30 | NA | intermittent theta burst stimulation using a MagPro X100, sham intermittent theta burst stimulation using a MagPro X100 | Third Affiliated Hospital, Sun Yat-Sen University | Multiple Sclerosis, Depression, Anxiety | 09/22 | 12/22 | | |
| Recruiting | N/A | 1500 | RoW | | Huashan Hospital, China Alliance for Rare Diseases, National Center for Neurological Disorders (China), China myasthenia gravis collaborating group (CMGCG) | Myasthenia Gravis | 02/34 | 01/35 | | |
